Differential changes in sphingolipids between TNF-induced necroptosis and apoptosis in U937 cells and necroptosis-resistant sublines

Leukemia Research

Volumn 39, Issue 9, 2015, Pages 964-970

  Sawai, Hirofumi ^a   Ogiso, Hideo ^b   Okazaki, Toshiro ^b  

^a OSAKA DENTAL UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Ceramide; Mass spectrometry; Necroptosis; Sphingolipids; TNF

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 8; CASPASE 9; CERAMIDE; GALACTOSYLCERAMIDE; GLUCOSYLCERAMIDE; GUAIACOL; LACTOSYLCERAMIDE; MONOHEXOSYLCERAMIDE; N LIGNOCERYL SPHINGOSINE; N NERVONOYL SPHINGOSINE; N PALMITOYL SPHINGOSINE; PHOSPHOTRANSFERASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; RIP1 KINASE; RIP3 KINASE; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; ANTIOXIDANT; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; BUTYLATED HYDROXYANISOLE; CASPASE INHIBITOR; PEPTIDE CHLOROMETHYL KETONE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BUTYLATION; CELL SHRINKAGE; CHEMICAL REACTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MEMBRANE BLEBBING; MEMBRANE PERMEABILITY; NECROPTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY; U937 CELL LINE; AGONISTS; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CHEMICALLY INDUCED; DEFICIENCY; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION; GENETICS; METABOLISM; NECROSIS; TUMOR CELL LINE;

AMINO ACID CHLOROMETHYL KETONES; ANTIOXIDANTS; APOPTOSIS; BUTYLATED HYDROXYANISOLE; CASPASE INHIBITORS; CELL LINE, TUMOR; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CERAMIDES; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; HUMANS; NECROSIS; REACTIVE OXYGEN SPECIES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 84940951823     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2015.06.002     Document Type: Article

References (25)

1. Hengartner M.O. The biochemistry of apoptosis. Nature 2000, 407:770-776.
2. Degterev A., Huang Z., Boyce M., Li Y., Jagtap P., Mizushima N., et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 2005, 1:112-119.
3. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972, 26:239-257.
4. Vercammen D., Brouckaert G., Denecker G., Van de Craen M., Declercq W., Fiers W., et al. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 1998, 188:919-930.
5. Degterev A., Hitomi J., Germscheid M., Ch'en I.L., Korkina O., Teng X., et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 2008, 4:313-321.
6. He S., Wang L., Miao L., Wang T., Du F., Zhao L., et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α. Cell 2009, 137:1100-1111.
7. Cho Y.S., Challa S., Moquin D., Genga R., Ray T.D., Guildford M., et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009, 137:1112-1123.
8. Sun L., Wang H., Wang Z., He S., Chen S., Liao D., et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012, 148:213-227.
9. Wang Z., Jiang H., Chen S., Du F., Wang X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 2012, 148:228-243.
10. Hannun Y.A. Functions of ceramide in coordinating cellular responses to stress. Science 1996, 274:1855-1859.
11. Sawai H., Hannun Y.A. Ceramide and sphingomyelinases in the regulation of stress responses. Chem. Phys. Lipids 1999, 102:141-147.
12. Hannun Y.A., Obeid L.M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 2008, 9:139-150.
13. Sawai H., Domae N., Okazaki T. Current status and perspectives in ceramide-targeting molecular medicine. Curr. Pharm. Des. 2005, 11:2479-2487.
14. Hannun Y.A., Obeid L.M. Many ceramides. J. Biol. Chem. 2011, 286:27855-27862.
15. Thon L., Mohlig H., Mathieu S., Lange A., Bulanova E., Winoto-Morbach S., et al. Ceramide mediates caspase-independent programmed cell death. FASEB J. 2005, 19:1945-1956.
16. Ogiso H., Taniguchi M., Araya S., Aoki S., Wardhani L.O., Yamashita Y., et al. Comparative analysis of biological sphingolipids with glycerophospholipids and diacylglycerol by LC-MS/MS. Metabolites 2014, 4:98-114.
17. Sawai H., Domae N. Discrimination between primary necrosis and apoptosis by necrostatin-1 in Annexin V-positive/propidium iodide-negative cells. Biochem. Biophys. Res. Commun. 2011, 411:569-573.
18. Sawai H. Characterization of TNF-induced caspase-independent necroptosis. Leuk. Res. 2014, 38:706-713.
19. 16-ceramide form large stable channels, Implications for apoptosis. J. Biol. Chem. 2000, 275:38640-38644.
20. Aouali N., El Btaouri H., Dumontet C., Eddabra L., Malagarie-Cazenave S., Madoulet C., et al. Accumulation of lactosylceramide and overexpression of a PSC833-resistant P-glycoprotein in multidrug-resistant human sarcoma cells. Oncol. Rep. 2011, 25:1161-1167.
21. Maceyka M., Harikumar K.B., Milstien S., Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2012, 22:50-60.
22. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 1995, 182:367-377.
23. Goossens V., Grooten J., De Vos K., Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:8115-8119.
24. Vercammen D., Beyaert R., Denecker G., Goossens V., Van Loo G., Declercq W., et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 1998, 187:1477-1485.
25. 2 acts on cellular membranes to generate ceramide signaling and initiate apoptosis in tracheobronchial epithelial cells. J. Cell Sci. 1998, 111:3209-3220.